Serial Number 97649707
731

Registration Progress

Application Filed
Oct 26, 2022
Under Examination
Feb 27, 2024
Approved for Publication
Jan 2, 2024
Published for Opposition
Jan 2, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 2 Granted
Due: Aug 27, 2025 22 days

Trademark Image

Basic Information

Serial Number
97649707
Filing Date
October 26, 2022
Published for Opposition
January 2, 2024
Drawing Code
2

Status Summary

Current Status
Active
Status Code
731
Status Date
Jan 30, 2025
Application
Pending
Classes
005 042

Rights Holder

Eikon Therapeutics, Inc.

03
Address
230 Harriet Tubman Way
Millbrae, CA 94030

Ownership History

Eikon Therapeutics, Inc.

Original Applicant
03
Hayward, CA

Eikon Therapeutics, Inc.

Owner at Publication
03
Millbrae, CA

Legal Representation

Attorney
Ilene B. Tannen

USPTO Deadlines

Next Deadline
22 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
August 27, 2025
Extension Available
Until February 27, 2025

Application History

29 events
Date Code Type Description Documents
Jun 25, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 25, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 25, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 25, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 25, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 30, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 30, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 30, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 30, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 26, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 26, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 26, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 26, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Feb 27, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 2, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 13, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 27, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 27, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Nov 27, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Nov 27, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Nov 27, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 29, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 9, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 10, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Nov 9, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 29, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations comprising small molecules, biologics being biopharmaceuticals, and biologically active substances for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; vaccines; pharmaceutical preparations for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; biopharmaceuticals in the nature of pharmaceutical preparations for the prevention and treatment of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; therapeutic pharmaceuticals for the prevention and treatment of diseases and disorders, namely, cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterological disorders, dermatological disorders, endocrine disorders, infectious diseases, and ophthalmological disorders; diagnostic substances, preparations, and agents for medical purposes
Class 042
Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials; Providing a website featuring technology that allows users to conduct drug discovery and development; Providing a website featuring technology that allows users to track and measure movement of proteins in living cells

Additional Information

Design Mark
The mark consists of a design of a circle that contains four connected lines, one of which extends past the outside of the circle. The lines form one incomplete triangle and one complete triangle. At the end of each line is a small shaded circle.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042